SightfileU.S. market data from official filings

NATIONAL VISION HLDGS INC COM (EYE)

Name: NATIONAL VISION HLDGS INC COM (EYE) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001710155 · EDGAR filings · Updated 2026-07-09

NATIONAL VISION HLDGS INC COM (EYE) has reported institutional ownership of 119.0%, with 257 institutional managers holding positions valued at $2.47B per the latest 13F reporting period.

Institutional ownership

119.0%

Institutional managers

257

Reported 13F value

$2.47B

Insider activity

74 trans.

−$5.22M net selling

Latest updates

2026-07-09 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NATIONAL VISION HLDGS INC COM has 257 institutional holders and institutional ownership of 119.0%.

Insider activity

Insiders reported 74 transactions (0 buys, 9 sells) across 17 reporting insiders, with a net reported value of −$5.22M.

Related companies

IMMUNOME INC (IMNM) · TYRA BIOSCIENCES INC (TYRA) · PRIVIA HEALTH GROUP INC (PRVA) · DENTSPLY SIRONA INC (XRAY) · MINERALYS THERAPEUTICS INC (MLYS) · ENLIVEN THERAPEUTICS INC (ELVN)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.